Literature DB >> 14674898

Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors.

G Severi1, R Sinclair, J L Hopper, D R English, M R E McCredie, P Boyle, G G Giles.   

Abstract

BACKGROUND: The epidemiology of androgenetic alopecia (AGA) is not fully understood. Although a strong genetic basis has long been identified, little is known of its non-genetic causes.
OBJECTIVES: To estimate the prevalence of and to determine risk factors for AGA in men aged 40-69 years in Australia.
METHODS: Men (n = 1390) were recruited at random from the electoral rolls to serve as controls in a population-based case-control study of prostate cancer. All were interviewed in person and direct observations of AGA were made. Men were grouped into the following categories; no AGA, frontal AGA, vertex AGA and full AGA (frontal and vertex AGA). Epidemiological data collected from these men were used for an analysis of risk factors for each AGA category using unconditional logistic regression with AGA category as the response variable adjusting for age, education and country of birth.
RESULTS: The prevalence of vertex and full AGA increased with age from 31% (age 40-55 years) to 53% (age 65-69 years). Conversely, the proportion of men with only frontal AGA was very similar across all age groups (31-33%). No associations were found between pubertal growth spurt or acne, reports of adult body size at time of interview, urinary symptom score, marital status, or current smoking status or duration of smoking and the risk of any form of AGA. The consumption of alcohol was associated with a significant increase in risk of frontal and vertex AGA but not full AGA. Men with vertex AGA had fewer female sexual partners but average ejaculatory frequency did not differ between men in different AGA categories. Reported weight and lean body mass at reaching maturity at about 21 years of age were negatively associated with vertex balding (P for trend < 0.05) but not with frontal AGA or full AGA.
CONCLUSIONS: Evidence for environmental influences on AGA remains very slight. Our study failed to confirm previously reported or hypothesized associations with smoking and benign prostatic hypertrophy. The associations that we found with alcohol consumption and with lean body mass at age 21 years would be worthy of further research if they were able to be replicated in other studies.

Entities:  

Mesh:

Year:  2003        PMID: 14674898     DOI: 10.1111/j.1365-2133.2003.05565.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  45 in total

1.  Oxidative stress-associated senescence in dermal papilla cells of men with androgenetic alopecia.

Authors:  James H Upton; Rosalind F Hannen; Adiam W Bahta; Nilofer Farjo; Bessam Farjo; Michael P Philpott
Journal:  J Invest Dermatol       Date:  2015-02-03       Impact factor: 8.551

Review 2.  The Use of Medicinal Plants for the Treatment of Alopecia in the Canon of Avicenna: An Evidence-Based Review.

Authors:  Zahra Boghrati; Sara Sabouri-Rad; Seyed Ahmad Emami; Mohsen Tahaghoghi Saber; Amirhossein Sahebkar; Zahra Tayarani-Najaran
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Androgenetic alopecia: a review.

Authors:  Francesca Lolli; Francesco Pallotti; Alfredo Rossi; Maria C Fortuna; Gemma Caro; Andrea Lenzi; Andrea Sansone; Francesco Lombardo
Journal:  Endocrine       Date:  2017-03-28       Impact factor: 3.633

4.  The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy.

Authors:  Ghazi Al Edwan; Bimal Bhindi; David Margel; Karen Chadwick; Antonio Finelli; Alexandre Zlotta; John Trachtenberg; Neil Fleshner
Journal:  Can Urol Assoc J       Date:  2016-12-12       Impact factor: 1.862

5.  Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels.

Authors:  Emre Can Polat; Levent Ozcan; Alper Otunctemur; Emin Ozbek
Journal:  Urolithiasis       Date:  2016-05-07       Impact factor: 3.436

6.  Androgenetic Alopecia Treatment in Asian Men.

Authors:  Yohei Tanaka; Toru Aso; Jumpei Ono; Ryu Hosoi; Takuto Kaneko
Journal:  J Clin Aesthet Dermatol       Date:  2018-07-01

7.  Relationship of early-onset baldness to prostate cancer in African-American men.

Authors:  Charnita Zeigler-Johnson; Knashawn H Morales; Elaine Spangler; Bao-Li Chang; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-26       Impact factor: 4.254

8.  Digit-Length Ratios (2D:4D) as a Phenotypic Indicator of in Utero Androgen Exposure is Not Prognostic for Androgenic Alopecia: a Descriptive-Analytic Study of 1200 Iranian Men.

Authors:  Amir Feily; Masoomeh Hosseinpoor; Ali Bakhti; Mohamad Nekuyi; Saeed Sobhanian; Zahra Fathinezhad; Reza Sahraei; Marigdalia K Ramirez-Fort
Journal:  Dermatol Reports       Date:  2016-06-15

Review 9.  Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.

Authors:  Jason M Hirshburg; Petra A Kelsey; Chelsea A Therrien; A Carlo Gavino; Jason S Reichenberg
Journal:  J Clin Aesthet Dermatol       Date:  2016-07-01

10.  Premature graying, balding, and low bone mineral density in older women and men: the Rancho Bernardo study.

Authors:  Deborah J Morton; Donna Kritz-Silverstein; Donna J Riley; Elizabeth L Barrett-Connor; Deborah L Wingard
Journal:  J Aging Health       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.